Pew Charitable Trusts is adding data from drugmaker Novartis’ now-defunct antibiotics research programs to its open source information-sharing platform in an effort to jump-start development of products to combat antimicrobial-resistant pathogens.
Pew Charitable Trusts is adding data from drugmaker Novartis’ now-defunct antibiotics research programs to its open source information-sharing platform in an effort to jump-start development of products to combat antimicrobial-resistant pathogens.